Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration
暂无分享,去创建一个
Wei Jia | Ke Wang | Guoxiang Xie | Mingming Su | Ningning Zheng | Yunping Qiu | G. Xie | W. Jia | Houkai Li | M. Su | Y. Qiu | Ke Wang | Houkai Li | N. Zheng | Jiaojiao He | Jiaojiao He | Yunping Qiu
[1] Meiping Guan,et al. Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients , 2013, PloS one.
[2] M. McCullough,et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. , 2010, Gastroenterology.
[3] M. V. Heiden,et al. Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.
[4] L. Marroquin,et al. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. , 2008, Toxicology and applied pharmacology.
[5] A. Segura‐Carretero,et al. Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs , 2012, Aging.
[6] Shih-Chieh Lin,et al. Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer. , 2011, The American journal of pathology.
[7] C. Bertolotto,et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. , 2010, Cancer research.
[8] P. Nangia-Makker,et al. Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer , 2014, PloS one.
[9] G. Stephanopoulos,et al. Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. , 2013, Cancer research.
[10] G. Xie,et al. Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice. , 2012, Journal of proteome research.
[11] Shailendra Giri,et al. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner , 2009, Journal of cellular and molecular medicine.
[12] H. Kan,et al. Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes , 2011, Diabetes Care.
[13] C. Toulas,et al. Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response , 2015, PloS one.
[14] T. Kourelis,et al. Metformin and cancer: new applications for an old drug , 2012, Medical Oncology.
[15] I. Ben-Sahra,et al. Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? , 2010, Molecular Cancer Therapeutics.
[16] Christian M. Metallo,et al. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. , 2011, Genes & development.
[17] R. Veale,et al. Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones) , 2014, BMC Cancer.
[18] J. Islamian,et al. Inhibition of tumor energy pathways for targeted esophagus cancer therapy. , 2015, Metabolism: clinical and experimental.
[19] M. Gunter,et al. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. , 2006, The Journal of nutritional biochemistry.
[20] G. Pond,et al. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK , 2013, British Journal of Cancer.
[21] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[22] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Struhl,et al. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells , 2014, Proceedings of the National Academy of Sciences.
[24] M. V. Vander Heiden,et al. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.
[25] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[26] Veronica Martinez Marignac,et al. Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition. , 2015, Journal of cancer research and therapeutics.
[27] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[28] Joaquín Dopazo,et al. Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data , 2010, Bioinform..
[29] M. Pollak,et al. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria , 2014, The Biochemical journal.
[30] Y. Choi,et al. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. , 2014, Cancer letters.
[31] Tianlu Chen,et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. , 2009, Journal of proteome research.
[32] Hirokazu Takahashi,et al. Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase , 2010, Molecular carcinogenesis.
[33] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[34] M. Ciriolo,et al. Managing lipid metabolism in proliferating cells: new perspective for metformin usage in cancer therapy. , 2014, Biochimica et biophysica acta.
[35] L. Balluz,et al. Association Between Diagnosed Diabetes and Self-Reported Cancer Among U.S. Adults , 2011, Diabetes Care.
[36] D. Xiao,et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy , 2012, Cell Death and Disease.